Combined Synopsis/SolicitationPosted Jul 22, 2026·Original deadline passed (Jul 30). See latest amendment for current deadline.

Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH NIDA

Stage
Open solicitation
NAICS
541690
Value
Not stated
Solicitation
75N95026R0007
Set-aside
No Set aside used
PSC
B529
Place
Bethesda, MD, USA
Contact
KNIGHTLY, ROBIN D (robin.knightly@nih.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75N95026R0007 in this department, oldest first.

Early notice
None posted
Solicitation
  • Jul 22, 2026
    Combined Synopsis/Solicitation
    Open
  • Jul 22, 2026 · this notice
    Combined Synopsis/Solicitation
  • Jul 27, 2026
    Combined Synopsis/Solicitation
    Open
Award
Not yet. Expected award: Any day (median passed). Typical range Aug 7, 2026 to Oct 13, 2026; middle Aug 19, 2026.
Measured from 139 past solicitations at National Institutes of Health that later posted an award (middle half of cases, counted from Jul 22, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV (i) This is a combined synopsis/solicitation for commercial items. This announcement constitutes the only solicitation; a written solicitation will not be issued. (ii) The solicitation number is 75N95026R0007. This solicitation is issued as a request for proposal (RFP). (iii) This solicitation document and incorporated provisions an… (show all)

d clauses are those in effect through Federal Acquisition Circular FAC 2026-01. (iv) This requirement is full and open with no set-aside restrictions. The associated NAICS Code is 541690 Other Scientific and Technical Consulting Services and the small business size standard is $19.0M. (v) The Government anticipates award of a firm fixed-price purchase order for the services acquired under this acquisition, and the anticipated period of performance is August 7, 2026 through August 6, 2027 with three (3) twelve-month option periods. (vi) Description of Requirement: The objective of the proposed project is to examine GLP-1RAs and their potential health benefits for PLWH, in addition to alcohol and substance use disorders outcomes. Using electronic health record data from the Department of Veterans Affairs (VA), the largest integrated healthcare system in the US, we will investigate the association between GLP-1RAs (prescribed for any indication) and HIV- and ASUD-related outcomes in adults. Individuals exposed to GLP-1RAs will be propensity-score matched to up to five unexposed individuals. Multivariable linear regression models will estimate changes in HIV- and ASUD-related outcomes before and after exposure. See attached Statement of Work for Specific Requirements (vii) Delivery: See attached Statement of Work for Specific Delivery or Deliverables. (viii) The provision at RFO 52.212-1, Instructions to Offerors�Commercial Products and Commercial Services, applies to this acquisition. (ix) The provision at RFO 52.212-2, Evaluation�Commercial Products and Commercial Services, applies to this acquisition. (a) Evaluation Factors. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be the most advantageous to the Government , price and other factors considered. The following factors will be used to evaluate offers: Technical capability Price Past performance Evaluation factors other than price when combined are significantly more important than price. (b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. The evaluation of options does not obligate the Government to exercise the option(s). (c) Notice of award. A written notice of award or acceptance of an offer furnished to the successful Offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer�s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x) The clause at RFO 52.212-4, Contract Terms and Conditions � Commercial Products and Commercial Services, applies to this acquisition. (xi) System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in this solicitation. Contracting officers will rely on representations from offers based on provisions in the solicitation. Entities are not required to, nor are they able to update their entity registration to remove these representations in SAM. (xii) No additional contract requirement(s) or terms and conditions have been determined by the contracting officer to be necessary for this acquisition and consistent with customer commercial practices. (xiii) The Defense Priorities and Allocations System (DPAS) is not applicable. (xiv) Submission Requirements: Responses to this solicitation must include clear and convincing evidence of the offeror�s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. (xv) The provision at RFO 52.251-1 Solicitation Provisions Incorporated by Reference (Feb 1998) applies to this solicitation. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this/these address(es): www.acquisition.gov The following provisions apply to this acquisition and are incorporated by reference: 52.203-11 Certification and Disclosure Regarding Payments to Influence Certain Federal Transactions 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements or Statements-Representation 52.204-7 System for Award Management � Registration 52.204-90 Offeror Identification 52.222-52 Exemption from Application of the Service Contract Labor Standards for Certain Services-Certification 52.217-8 Option to Extend Services 52.217-9 Option to Extend the Term of the Contract 52.223-4 Recovered Material Certification 52.240-90 Security Prohibition and Exclusions Representations and Certifications (xvi) The clause at RFO 52.252-2, Clause Incorporated by Reference (Feb 1998) applies to this solicitation. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): www.acquisition.gov The following clauses apply to this acquisition and are incorporated by reference: 52.203-6 with Alt 1 Restrictions on Subcontractor Sales to the Government 52.203-17 Contractor Employee Whistleblower Rights 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements 52.204-13 System for Award Management- Maintenance 52.204-91 Contractor Identification 52.209-6 Protecting the Government�s Interest When Subcontracting with Contractors, Debarred, Suspended, or Proposed for Debarment 52.209-10 Prohibition on Contracting with Inverted Domestic Corporations 52.219-4 Notice of Price Evaluation Preference for HUBZone Small Business Concerns 52.219-8 Utilization of Small Business Concerns 52.222-3 Convict Labor 52.222-35 Equal Opportunity for Veterans 52.222-36 Equal Opportunity for Workers with Disabilities 52.222-37 Employment Reports on Veterans 52.222-40 Notification of Employee Rights Under the National Labor Relations Act 52.222-41 Service Contract Labor Standards 52.222-42 Statement of Equivalent Rates for Federal Hires 52.222-43 Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (Multiple Year and Option Contracts) 52.222-44 Fair Labor

Who won similar work

4 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH NIDA), same NAICS 541690.

Single-winner award sizes (4): middle half $191K to $3.9M, median $649K; range $12K to $12.3M.

WinnerAwardsValueLast
DATACONSULT-IO LLC1$12.3MAug 1, 2025
BHI MANAGEMENT INC1$1.0MSep 29, 2025
ARALDI GIAN LUCA San Marcos CA 92069 USA1$250KSep 16, 2025
MIDNIGHT SUN PROFESSIONAL SOLUTIONS LLC1$12KNov 17, 2025

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Latest awards

Competitive landscape

For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.